HARRY J LEONHARDT
CIK 1286102 · GC & Chief Compliance Officer · last filed 2025-01-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
4
Total Filings
34
Lifetime Open-Market Net
-$356.7K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Poseida Therapeutics, Inc. (PSTX) Delisted | GC & Chief Compliance Officer | 0 | $9.50 | $0 | $0 | 5 | 2025-01-08 |
| HALOZYME THERAPEUTICS, INC. (HTI) Delisted | SVP, GC | 66,373 | — | — | $0 | 15 | 2019-04-15 |
| AMYLIN PHARMACEUTICALS INC (AMLN) Delisted | SVP, Legal, Compliance and Cor | 39,431 | — | — | -$58.2K | 5 | 2012-03-07 |
| SENOMYX INC (SNMX) Delisted | SVP, Gen.Counsel & Corp. Sec. | 48,937 | — | — | -$298.6K | 8 | 2007-09-04 |
Recent Filings · Page 2 of 4
34 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-04-13 | HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Mixed | +4,498 | -$46.0K | EDGAR |
| 2018-02-23 | HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Mixed | +7,453 | -$75.9K | EDGAR |
| 2018-02-16 | HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-02-05 | HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Mixed | +9,808 | -$103.0K | EDGAR |
| 2017-04-14 | HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Mixed | +4,292 | -$33.1K | EDGAR |
| 2017-02-24 | HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-02-06 | HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Mixed | +9,215 | -$76.0K | EDGAR |
| 2016-04-14 | HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Mixed | +4,292 | -$30.4K | EDGAR |
| 2016-02-04 | HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-04-15 | HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.